Lessons Learned From Fatal Progressive Multifocal Leukoencephalopathy in a Patient With Multiple Sclerosis Treated With Natalizumab
Boster AL, Nicholas JA, Topalli I, Kisanuki YY, Pei W, Morgan-Followell B, Kirsch CF, Racke MK, Pitt D. Lessons Learned From Fatal Progressive Multifocal Leukoencephalopathy in a Patient With Multiple Sclerosis Treated With Natalizumab. JAMA Neurology 2013, 70: 398-402. PMID: 23338729, DOI: 10.1001/jamaneurol.2013.1960.Peer-Reviewed Original ResearchConceptsProgressive multifocal leukoencephalopathyBrain magnetic resonance imagingMagnetic resonance imagingMultiple sclerosisResonance imagingMultifocal leukoencephalopathyPolymerase chain reaction testingFatal progressive multifocal leukoencephalopathyBenefits of natalizumabInfusions of natalizumabPML risk stratificationAntibody-positive patientsHigh-dose corticosteroidsCerebrospinal fluid studiesHigh clinical suspicionCerebrospinal fluid analysisBrain magnetic resonanceNegative test resultsPolymerase chain reaction resultsSubacute onsetBilateral blindnessClinical suspicionClinical vigilanceCortical demyelinationTherapy duration
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply